X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (278) 278
Publication (25) 25
Book Review (23) 23
Newspaper Article (11) 11
Conference Proceeding (9) 9
Book Chapter (3) 3
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (156) 156
index medicus (154) 154
female (107) 107
male (100) 100
oncology (100) 100
middle aged (98) 98
adult (85) 85
aged (83) 83
cancer (57) 57
medicine & public health (54) 54
glioblastoma (50) 50
prognosis (46) 46
clinical neurology (45) 45
chemotherapy (37) 37
radiotherapy (33) 33
glioblastoma multiforme (32) 32
tumors (32) 32
temozolomide (31) 31
brain neoplasms - pathology (30) 30
survival (30) 30
gliomas (29) 29
brain neoplasms - drug therapy (28) 28
brain neoplasms - mortality (28) 28
aged, 80 and over (26) 26
glioblastoma - mortality (25) 25
malignant glioma (25) 25
medicine/public health, general (24) 24
young adult (24) 24
retrospective studies (23) 23
glioblastoma - pathology (22) 22
quality of life (22) 22
glioblastoma - drug therapy (21) 21
survival analysis (21) 21
dacarbazine - analogs & derivatives (20) 20
internal medicine (20) 20
prospective studies (20) 20
survival rate (20) 20
glioma (19) 19
brain tumors (18) 18
care and treatment (18) 18
medical colleges (18) 18
antineoplastic agents - therapeutic use (17) 17
brain neoplasms - therapy (17) 17
follow-up studies (17) 17
magnetic resonance imaging (17) 17
brain cancer (16) 16
combined modality therapy (16) 16
expression (16) 16
surgery (16) 16
treatment outcome (16) 16
brain neoplasms - diagnosis (15) 15
dna methylation (15) 15
glioblastoma - genetics (15) 15
immunohistochemistry (15) 15
risk factors (15) 15
adjuvant temozolomide (14) 14
adolescent (14) 14
analysis (14) 14
antineoplastic agents, alkylating - therapeutic use (14) 14
brain neoplasms - metabolism (14) 14
brain-tumors (14) 14
hematology (14) 14
neurology (14) 14
pathology (14) 14
dacarbazine - administration & dosage (13) 13
glioma - pathology (13) 13
neurosciences (13) 13
therapy (13) 13
venous thromboembolism (13) 13
bevacizumab (12) 12
brain neoplasms - genetics (12) 12
dacarbazine - therapeutic use (12) 12
glioblastoma - radiotherapy (12) 12
methylation (12) 12
research (12) 12
cells (11) 11
dna modification methylases - genetics (11) 11
glioblastoma - therapy (11) 11
kaplan-meier estimate (11) 11
medicine (11) 11
neoplasms (11) 11
newly-diagnosed glioblastoma (11) 11
tumor suppressor proteins - genetics (11) 11
abridged index medicus (10) 10
biomarker (10) 10
brain metastases (10) 10
brain neoplasms - radiotherapy (10) 10
disease progression (10) 10
dna repair enzymes - genetics (10) 10
glioblastoma - diagnosis (10) 10
health aspects (10) 10
medicine, general & internal (10) 10
mortality (10) 10
multiforme (10) 10
palliative care (10) 10
patients (10) 10
phase-ii (10) 10
austria (9) 9
brain (9) 9
brain neoplasms - secondary (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 916 - 926
Journal Article
Lancet Oncology, ISSN 1470-2045, 2009, Volume 10, Issue 5, pp. 459 - 466
Journal Article
Nature Reviews Neurology, ISSN 1759-4758, 02/2017, Volume 13, Issue 2, pp. 71 - 72
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1521 - 1532
Journal Article
memo - Magazine of European Medical Oncology, ISSN 1865-5041, 4/2015, Volume 8, Issue 1, pp. 5 - 10
Cancer is still the second cause of death in Europe and with the aging of populations, the number of cancer patients will further increase. For Austria, the... 
Targeted therapies | Medicine & Public Health | Sex | Oncology | Pharmacokinetics | Medicine/Public Health, general | Epidemiology | Cancer | Medical colleges | Analysis
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2011, Volume 29, Issue 15, pp. 2099 - 2103
Purpose Patients with cancer are at increased risk of venous thromboembolism (VTE). Laboratory tests measuring the overall thrombophilic tendency might be... 
MARKERS | COAGULATION | RECURRENCE | ONCOLOGY | INCREASED RISK | D-DIMER | Neoplasms - complications | Predictive Value of Tests | Risk Assessment | Humans | Middle Aged | Venous Thromboembolism - complications | Thrombin - analysis | Female | Male | Index Medicus
Journal Article
by Weller, Michael and Butowski, Nicholas and Tran, David D and Recht, Lawrence and Recht, Lawrence D and Lim, Michael and Hirte, Hal and Ashby, Lynn and Mechtler, Laszlo and Goldlust, Samuel and Goldlust, Samuel A and Iwamoto, Fabio and Drappatz, Jan and O'Rourke, James and O'Rourke, Donald M and Wong, Mark and Hamilton, Mark G and Hamilton, Mark and Finocchiaro, Gaetano and Perry, James and Wick, Wolfgang and Green, Jennifer and He, Yi and Turner, Christopher D and Yellin, Michael J and Keler, Tibor and Davis, Thomas A and Stupp, Roger and Sampson, John H and Campian, Jian and Becker, Kevin and Barnett, Gene and Nicholas, Garth and Desjardins, Annick and Benkers, Tara and Wagle, Naveed and Groves, Morris and Kesari, Santosh and Horvath, Zsolt and Merrell, Ryan and Curry, Richard and Schuster, David and Mrugala, Maciej and Jensen, Randy and Trusheim, John and Lesser, Glenn and Belanger, Karl and Sloan, Andrew and Purow, Benjamin and Fink, Karen and Raizer, Jeffrey and Schulder, Michael and Nair, Suresh and Peak, Scott and Brandes, Alba and Mohile, Nimish and Landolfi, Joseph and Olson, Jon and Jennens, Ross and DeSouza, Paul and Robinson, Bridget and Crittenden, Marka and Shih, Kent and Flowers, Alexandra and Ong, Shirley and Connelly, Jennifer and Hadjipanayis, Costas and Giglio, Pierre and Mott, Frank and Mathieu, David and Lessard, Nathalie and Sepulveda, Sanchez Juan and Lövey, József and Wheeler, Helen and Inglis, Po-Ling and Hardie, Claire and Bota, Daniela and Lesniak, Maciej and Portnow, Jana and Frankel, Bruce and Junck, Larry and Thompson, Reid and Berk, Lawrence and McGhie, John and Macdonald, David and Saran, Frank and Soffietti, Riccardo and Blumenthal, Deborah and André de, Sá Barreto Costa Marcos and Nowak, Anna and Singhal, Nimit and Hottinger, Andreas and Schmid, Andrea and Srkalovic, Gordan and Baskin, David and Fadul, Camilo and Nabors, Louis and LaRocca, Renato and Villano, John and Paleologos, Nina and ... and ACT IV Trial Investigators and ACT IV trial investigators
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1373 - 1385
Rindopepimut (also known as CDX-110), a vaccine targeting the deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet... 
GLIOMAS | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | GROWTH-FACTOR | RADIOTHERAPY | CANCER | PEPTIDE | ADJUVANT TEMOZOLOMIDE | Receptor, Epidermal Growth Factor - genetics | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Dose-Response Relationship, Drug | Young Adult | Glioblastoma - genetics | Time Factors | Dacarbazine - analogs & derivatives | Adult | Female | Vaccines, Subunit - adverse effects | Brain Neoplasms - mortality | Dacarbazine - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Cancer Vaccines - adverse effects | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Internationality | Vaccines, Subunit - administration & dosage | Glioblastoma - pathology | Survival Analysis | Aged | Glioblastoma - drug therapy | Glioblastoma - mortality | Antimitotic agents | Clinical trials | Care and treatment | Product development | Antineoplastic agents | Glioblastoma multiforme | Analysis | Index Medicus
Journal Article
Journal Article